| Product NDC: | 10019-027 |
| Proprietary Name: | Midazolam Hydrochloride |
| Non Proprietary Name: | Midazolam Hydrochloride |
| Active Ingredient(s): | 5 mg/mL & nbsp; Midazolam Hydrochloride |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 10019-027 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075243 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100304 |
| Package NDC: | 10019-027-07 |
| Package Description: | 10 VIAL, SINGLE-DOSE in 1 PACKAGE (10019-027-07) > 2 mL in 1 VIAL, SINGLE-DOSE (10019-027-59) |
| NDC Code | 10019-027-07 |
| Proprietary Name | Midazolam Hydrochloride |
| Package Description | 10 VIAL, SINGLE-DOSE in 1 PACKAGE (10019-027-07) > 2 mL in 1 VIAL, SINGLE-DOSE (10019-027-59) |
| Product NDC | 10019-027 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Midazolam Hydrochloride |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20100304 |
| Marketing Category Name | ANDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | MIDAZOLAM HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |